Gilead Sciences Investment Purchases decreased by 62.0% to $525.00M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Investment Purchases shows relatively stable performance with a 1.3% CAGR.
An increase may indicate a strategy to earn interest on excess cash, while a decrease may suggest a need for cash for operations or debt repayment.
This metric captures the cash outflow for the purchase of marketable securities, such as stocks, bonds, or other financi...
Standard for large-cap companies with significant cash reserves; peers manage these portfolios to balance liquidity needs with yield generation.
purchases_of_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.15B | $813.00M | $626.00M | $613.00M | $477.00M | $308.00M | $372.00M | $527.00M | $578.00M | $369.00M | $456.00M | $244.00M | $0.00 | $2.00B | $270.00M | $1.38B | $525.00M |
| QoQ Change | — | -29.1% | -23.0% | -2.1% | -22.2% | -35.4% | +20.8% | +41.7% | +9.7% | -36.2% | +23.6% | -46.5% | -100.0% | — | -86.5% | +411.9% | -62.0% |
| YoY Change | — | — | — | — | -58.4% | -62.1% | -40.6% | -14.0% | +21.2% | +19.8% | +22.6% | -53.7% | -100.0% | — | — | — | — |